Key points• There are two major ionotropic purinoceptor subtypes (ATP-gated, non-selective, Ca 2+ -conducting ion channels) in the salivary gland.• Relatively little is known about the physiological roles of these purinoceptors regarding compartmentalization and selective activation, their contributions to the spatiotemporal properties of intracellular Ca 2+ signals and their roles in regulating protein exocytosis and ion channel activity.• In this study, we investigated the subtype-specific sub-cellular distribution and functional characterization of purinoceptors in mouse parotid acinar cells.• Selective activation of ionotropic purinergic receptor subtypes was shown to evoke spatially distinct cytosolic Ca 2+ signals as well as protein exocytosis.• This study identifies a subtype of ionotropic purinergic receptors as a potential therapeutic target for treatment of salivary gland hypofunction.Abstract There is emerging consensus that P2X 4 and P2X 7 ionotropic purinoceptors (P2X 4 R and P2X 7 R) are critical players in regulating [Ca 2+ ] i dynamics and fluid secretion in the salivary gland. In contrast, details regarding their compartmentalization and selective activation, contributions to the spatiotemporal properties of intracellular signals and roles in regulating protein exocytosis and ion channel activity have remained largely undefined. To address these concerns, we profiled mouse parotid acinar cells using live-cell imaging to follow the spatial and temporal features of ATP-evoked Ca 2+ dynamics and exocytotic activity. Selective activation of P2X 7 Rs revealed an apical-to-basal [Ca 2+ ] i signal that initiated at the sub-luminal border and propagated with a wave speed estimated at 17.3 ± 4.3 μm s −1 (n = 6). The evoked Ca 2+ spike consisted of Ca 2+ influx and Ca 2+ -induced Ca 2+ release from intracellular Ca 2+ channels. In contrast, selective activation of P2X 4 Rs induced a Ca 2+ signal that initiated basally and propagated toward the lumen with a wave speed of 4.3 ± 0.2 μm s −1 (n = 8) that was largely independent of intracellular Ca 2+ channel blockade. Consistent with these observations, P2X 7 R expression was enriched in the sub-luminal regions of acinar cells while P2X 4 R appeared localized to basal areas. In addition, we showed that P2X 4 R and P2X 7 R activation evokes exocytosis in parotid acinar cells. Our studies also demonstrate that the P2X 4 R-mediated [Ca 2+ ] i rise and subsequent protein exocytosis was enhanced by ivermectin (IVR). Thus, in addition to furthering our understanding of salivary gland physiology, this study identifies P2X 4 R as a potential target for treatment of salivary hypofunction diseases.
Extended abstract of a paper presented at Microscopy and Microanalysis 2012 in Phoenix, Arizona, USA, July 29 – August 2, 2012.
(10-5M), inhibitors of PI3K, largely reduced UcnII-induced phosphorylation of Akt and eNOS, respectively (n=11-20, P<0.05). Cellular NO production increased by 41.155.5% (n=20, P<0.01), which was inhibited by eNOS inhibitors, L-NIO (10-5M) and L-NAME (1mM) by~30% (n=4-8, P<0.05). Inhibition of PKA by H89 (5x10-6M) also reduced eNOS phosphorylation (n=11, P<0.05) but did not affect Akt phosphorylation. Direct stimulation of cAMP/PKA signaling via forskolin (10-5M) increased phosphorylation of eNOS (n=5, P<0.05) but not of Akt. When both PI3K/Akt (LY294002 10-5M) and cAMP/PKA (H89 10-6M) signaling were inhibited, the UcnIIinduced increase of [NO]i was attenuated by~20% (n=10, P<0.01). UcnII also increased [NO]i in mouse, rat, and human ventricular myocytes as well as in rabbit atrial myocytes (n=4-12). SUMMARY: We conclude that, in cardiac myocytes, UcnII causes eNOS phosphorylation to stimulate cellular NO production via both cAMP/PKA and PI3K/Akt signaling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.